WASHINGTON — State and local officials throughout the country who are anxious for more doses of COVID-19 vaccines were told this week that supply will remain stagnant for most of this month, but should surge in the last days of March through the beginning of April.
A White House official told McClatchy that flat supply over the course of March is due to widely anticipated shortfalls from Johnson & Johnson, one of three authorized vaccine manufacturers. The supply of the one-shot J&J vaccines will increase in roughly two weeks.
Public health officials are able to see their projected vaccine supply up to three weeks in advance through a federal vaccine tracking system called Tiberius, and what they are seeing is a flat line through the end of March.
